The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
Open Access
- 10 October 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (9) , 1145-1147
Abstract
It is thought that the time interval between the antecedent pregnancy and diagnosis of gestational trophoblastic tumours (GTTs) may influence the outcome of these patients. In this study, we investigate the significance of this time interval. Multivariate analysis was used to investigate if the time interval was of prognostic significance from our cohort of 241 high-risk patients with GTT. Subsequent cutpoint analysis was used to determine an optimal cutpoint for the interval covariate. The outcome of these patients was plotted according to the Kaplan–Meier method. The time interval was of prognostic significance on multivariate analysis. A period of greater than 2.8 years after pregnancy was found to be of most significance. The 5-year overall survival was 62.0% (95% CI: 47–76%) for greater than 2.8 years vs 94% (95% CI: 91–97%) for less than 2.8 years (P<0.001). Multivariate analysis showed the presence of liver metastasis and the number of metastasis was also of prognostic importance. The interval between antecedent pregnancy and diagnosis in high-risk GTT is of prognostic significance. This gives some insight into the pathogenesis of the disease.Keywords
This publication has 10 references indexed in Scilit:
- Twenty-five years' clinical experience with placental site trophoblastic tumors.2002
- Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000Journal of Clinical Oncology, 2002
- The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessmentInternational Journal of Gynecological Cancer, 2001
- Effects of multiagent chemotherapy and independent risk factors in the treatment of high‐risk GTT —25 years experiences of KRI‐TRDInternational Journal of Gynecology & Obstetrics, 1998
- Management of resistant gestational trophoblastic tumors.1998
- EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.Journal of Clinical Oncology, 1997
- Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.1992
- Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma.Journal of Clinical Oncology, 1989
- Prognostic Factors in Testicular Germ Cell Tumours Experiences from 1058 Consecutive CasesActa Radiologica: Oncology, 1984
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976